Ownership history in Frazier Life Sciences Management, L.P. · 6 quarters on record
This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in AVIDITY BIOSCIENCES INC (RNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 983,125 | +358,125 | +57.3% | 1.90% | $70.9M | — |
| 2025 Q3 | UNCHANGED | 625,000 | — | 0% | 0.82% | $27.2M | — |
| 2025 Q2 | ADDED | 625,000 | +100,000 | +19.0% | 0.71% | $17.8M | — |
| 2025 Q1 | ADDED | 525,000 | +25,000 | +5.0% | 0.71% | $15.5M | — |
| 2023 Q1 | UNCHANGED | 500,000 | — | 0% | 0.56% | $7.7M | — |
| 2022 Q4 | INITIATED | 500,000 | — | — | 0.69% | $11.1M | — |
As of 2025 Q4 — sorted by position size